Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Infliximab in the treatment of medically refractory indeterminate colitis.

Papadakis KA, Treyzon L, Abreu MT, Fleshner PR, Targan SR, Vasiliauskas EA. Infliximab in the treatment of medically refractory indeterminate colitis. Aliment Pharmacol Ther. 2003 Oct 01; 18(7):741-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.